A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...

The study, co-led by Dr. Arun Sanyal of VCU’s Stravitz-Sanyal Institute for Liver Disease ... where semaglutide has already shown established health benefits.” MASH is closely linked to ...

Using semaglutide ... Institute for Liver Disease and Metabolic Health, in a video from VCU. “It provides patients with additional choices when we think about treating fatty liver disease.” ...

Experts are interested in understanding additional potential health benefits of semaglutide ... a serious form of fatty liver disease. The use of semaglutide, a medication from the class of ...

A popular drug for treating obesity and diabetes is now showing benefits in fighting a deadly liver disease. Semaglutide ... the severe form of non-alcoholic fatty liver disease marked by ...